NASDAQ NMS - GLOBAL MARKET · LIXT
-14.76% · -$1.07 · Vol 871.8K
Lixte Biotechnology Holdings Inc

Lixte Biotechnology Holdings Inc

Biotechnology
$6.18
+ Add to watchlist
Card

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
Sovereign

Why is LIXT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Lixte Biotechnology Holdings Inc
PHARMACEUTICAL PREPARATIONS
Founded
—
Listed
2007
Employees
3
HQ
US

Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.

Company website →
Key statistics

Real vendor fields plus Veridion-computed history. Missing fields stay blank.

Open
$7.11
Day high
$7.11
Day low
$5.88
Previous close
$7.25
52W high
$7.11
-13.08% from high
52W low
$5.88
25% of range
Market cap
$107.6M
P/E
—
EPS
—
Dividend yield
—
Beta
—
Shares out
17.4M
Float
—
Volume
871.8K
Avg volume
—
VWAP
$6.37
Next earnings
—
Price history computed in-house
1W
-10.30%
1M
-10.30%
3M
-10.30%
1Y
-10.30%
YTD
-10.30%
SMA 50 $6.61 · below
SMA 200 $6.61 · below
52W position 25%
Veridion warehouse edge

Warehouse intelligence for LIXT.

Veridion Score
59
0: 271: 462: 893: —4: —5: 60
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
—
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

LIXT insider activity

Lixte Biotechnology Holdings Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
$0
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: $0 across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for LIXT.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

LIXT contract awards, year to date.

Public federal awards linked to this ticker.

—
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LIXT in this window.
Lobbying spend

LIXT lobbying filings, year to date.

Registered lobbying filings matched to Lixte Biotechnology Holdings Inc.

—
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LIXT in this window.
Latest news · LIXT
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Sovereign unlock shows live analyst consensus for LIXT.
Options
Sovereign unlock shows live options positioning for LIXT.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.